ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial
The Lancet Neurology
◽
10.1016/s1474-4422(21)00298-2
◽
2021
◽
Vol 20
(11)
◽
pp. 907-916
Author(s):
Floris H B M Schreuder
◽
Koen M van Nieuwenhuizen
◽
Jeannette Hofmeijer
◽
Sarah E Vermeer
◽
Henk Kerkhoff
◽
...
Keyword(s):
Atrial Fibrillation
◽
The Netherlands
◽
Intracerebral Haemorrhage
◽
Phase 2
◽
Open Label
◽
Phase 2 Trial
◽
Open Label Phase
Download Full-text
Related Documents
Cited By
References
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial
The Lancet Neurology
◽
10.1016/s1474-4422(16)30234-4
◽
2016
◽
Vol 15
(12)
◽
pp. 1228-1237
◽
Cited By ~ 147
Author(s):
Daniel F Hanley
◽
Richard E Thompson
◽
John Muschelli
◽
Michael Rosenblum
◽
Nichol McBee
◽
...
Keyword(s):
Minimally Invasive Surgery
◽
Minimally Invasive
◽
Invasive Surgery
◽
Intracerebral Haemorrhage
◽
Phase 2
◽
Open Label
◽
Safety And Efficacy
◽
Phase 2 Trial
◽
Open Label Phase
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.726858225.793557568
◽
2019
◽
Author(s):
Jose Biller
Keyword(s):
Minimally Invasive Surgery
◽
Minimally Invasive
◽
Invasive Surgery
◽
Intracerebral Haemorrhage
◽
Phase 2
◽
Open Label
◽
Safety And Efficacy
◽
Phase 2 Trial
◽
Open Label Phase
◽
Randomised Controlled
Download Full-text
Dose-Adjusted EPOCH Regimen as First-Line Treatment for Non-Hodgkin's Lymphoma with Hemophagocytic Lymphohistiocytosis: A Single-Arm, Open-Label, Phase 2 Trial
SSRN Electronic Journal
◽
10.2139/ssrn.3304299
◽
2018
◽
Author(s):
Jin-Hua Liang
◽
Li Wang
◽
Hua-Yuan Zhu
◽
Jun Qian
◽
Hui Liao
◽
...
Keyword(s):
Hemophagocytic Lymphohistiocytosis
◽
Hodgkin's Lymphoma
◽
Line Treatment
◽
Phase 2
◽
First Line
◽
Open Label
◽
Phase 2 Trial
◽
Non Hodgkin's Lymphoma
◽
Open Label Phase
◽
First Line Treatment
Download Full-text
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial
The Lancet Respiratory Medicine
◽
10.1016/s2213-2600(20)30362-3
◽
2021
◽
Cited By ~ 2
Author(s):
Cornedine J de Gooijer
◽
Vincent van der Noort
◽
Jos A Stigt
◽
Paul Baas
◽
Bonne Biesma
◽
...
Keyword(s):
Malignant Mesothelioma
◽
Phase 2
◽
First Line
◽
Open Label
◽
Phase 2 Trial
◽
Open Label Phase
◽
Line Chemotherapy
Download Full-text
Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial
The Lancet Haematology
◽
10.1016/s2352-3026(21)00030-2
◽
2021
◽
Vol 8
(4)
◽
pp. e289-e298
◽
Cited By ~ 1
Author(s):
Lu Sun
◽
Juan Wang
◽
Linlin Shao
◽
Chenglu Yuan
◽
Hongguo Zhao
◽
...
Keyword(s):
Immune Thrombocytopenia
◽
Phase 2
◽
Open Label
◽
Phase 2 Trial
◽
Primary Immune Thrombocytopenia
◽
Open Label Phase
◽
Treatment Naïve
Download Full-text
Faculty Opinions recommendation of [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.739562946.793583755
◽
2021
◽
Author(s):
Patrick Richard
Keyword(s):
Prostate Cancer
◽
Phase 2
◽
Castration Resistant Prostate Cancer
◽
Open Label
◽
Phase 2 Trial
◽
Castration Resistant
◽
Open Label Phase
Download Full-text
Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial
The Lancet
◽
10.1016/s0140-6736(14)61795-5
◽
2015
◽
Vol 385
(9973)
◽
pp. 1075-1086
◽
Cited By ~ 208
Author(s):
Eric Lawitz
◽
Edward Gane
◽
Brian Pearlman
◽
Edward Tam
◽
Wayne Ghesquiere
◽
...
Keyword(s):
Hepatitis C Virus
◽
Hepatitis C
◽
Phase 2
◽
Efficacy And Safety
◽
Genotype 1
◽
Virus Genotype
◽
Open Label
◽
Phase 2 Trial
◽
Open Label Phase
◽
Null Response
Download Full-text
Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial
The Lancet Infectious Diseases
◽
10.1016/s1473-3099(18)30480-8
◽
2019
◽
Vol 19
(1)
◽
pp. 46-55
◽
Cited By ~ 9
Author(s):
Jung-Kyu Lee
◽
Ji Yeon Lee
◽
Deog Kyeom Kim
◽
Ho Il Yoon
◽
Ina Jeong
◽
...
Keyword(s):
Pulmonary Tuberculosis
◽
Phase 2
◽
Open Label
◽
Intensive Phase
◽
Phase 2 Trial
◽
Open Label Phase
Download Full-text
Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial
The Lancet Haematology
◽
10.1016/s2352-3026(17)30170-9
◽
2017
◽
Vol 4
(10)
◽
pp. e487-e496
◽
Cited By ~ 7
Author(s):
Fei-Er Feng
◽
Ru Feng
◽
Min Wang
◽
Jia-Min Zhang
◽
Hao Jiang
◽
...
Keyword(s):
Immune Thrombocytopenia
◽
Line Treatment
◽
Second Line
◽
Phase 2
◽
Open Label
◽
Phase 2 Trial
◽
Trans Retinoic Acid
◽
All Trans Retinoic Acid
◽
Primary Immune Thrombocytopenia
◽
Open Label Phase
Download Full-text
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
The Lancet Oncology
◽
10.1016/s1470-2045(14)70455-3
◽
2014
◽
Vol 15
(12)
◽
pp. 1311-1318
◽
Cited By ~ 160
Author(s):
Nathan H Fowler
◽
R Eric Davis
◽
Seema Rawal
◽
Loretta Nastoupil
◽
Fredrick B Hagemeister
◽
...
Keyword(s):
Phase 2
◽
Indolent Lymphoma
◽
Open Label
◽
Phase 2 Trial
◽
Open Label Phase
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close